cGAS is integral in several cellular responses to DNA damage, which can lead to the onset and progression of GI cancers or, alternatively, anti-tumor immunity (Garland et al., 2021; Samson and Ablasser, 2022). The gene discussed is CGAS; the disease is neoplasm.